| Meridian Health Services Corp. | |
|
8707 W Us Highway 36 Rm N2 Modoc IN 47358-9583 | |
| (765) 288-1928 | |
| Not Available |
| Full Name | Meridian Health Services Corp. |
|---|---|
| Speciality | Clinic/Center |
| Location | 8707 W Us Highway 36 Rm N2, Modoc, Indiana |
| Authorized Official Name and Position | Gary Gates (REVENUE CYCLE MANAGER) |
| Authorized Official Contact | 7652542685 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Meridian Health Services Corp. 240 N Tillotson Ave Muncie IN 47304-3988 Ph: (765) 288-1928 | Meridian Health Services Corp. 8707 W Us Highway 36 Rm N2 Modoc IN 47358-9583 Ph: (765) 288-1928 |
| NPI Number | 1821794116 |
|---|---|
| Provider Enumeration Date | 02/07/2023 |
| Last Update Date | 02/07/2023 |
| Medicare PECOS PAC ID | 5597679845 |
|---|---|
| Medicare Enrollment ID | O20230209002413 |
News Archive
Researchers from GE Global Research have been awarded a $538,000 human microbiome project from the National Institutes of Health (NIH) to develop new technology that would allow for the study of individual cells growing inside and outside the body believed to have a significant impact on human health.
XenoPort, Inc. announced today preliminary top-line results from a Phase 2b clinical trial of arbaclofen placarbil (also known as AP) as adjunctive therapy in patients with gastroesophageal reflux disease (GERD) who do not experience complete relief of GERD symptoms while being treated with proton pump inhibitors (PPI).
Vernalis Therapeutics Inc., a subsidiary of Vernalis plc, today announced that Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), extended-release oral suspension, CIII (DEA Schedule III) is now available to adult patients and physicians in the United States.
The MetLife Foundation has awarded The Gerontological Society of America (GSA) and New America Media (NAM) $100,000 in new grant funding for a fellowship program that will bring aging-focused reporters to GSA's Annual Scientific Meeting in Boston this November. Half of the invited participants will be chosen from ethnic media outlets.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821794116 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Researchers from GE Global Research have been awarded a $538,000 human microbiome project from the National Institutes of Health (NIH) to develop new technology that would allow for the study of individual cells growing inside and outside the body believed to have a significant impact on human health.
XenoPort, Inc. announced today preliminary top-line results from a Phase 2b clinical trial of arbaclofen placarbil (also known as AP) as adjunctive therapy in patients with gastroesophageal reflux disease (GERD) who do not experience complete relief of GERD symptoms while being treated with proton pump inhibitors (PPI).
Vernalis Therapeutics Inc., a subsidiary of Vernalis plc, today announced that Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), extended-release oral suspension, CIII (DEA Schedule III) is now available to adult patients and physicians in the United States.
The MetLife Foundation has awarded The Gerontological Society of America (GSA) and New America Media (NAM) $100,000 in new grant funding for a fellowship program that will bring aging-focused reporters to GSA's Annual Scientific Meeting in Boston this November. Half of the invited participants will be chosen from ethnic media outlets.
› Verified 9 days ago